The pharmaceutical industry is at a pivotal point and, despite unprecedented global demand for its product, must fundamentally change its entire approach in order to remain relevant to the healthcare needs of the world by the year 2020. That's the opinion of a new report, Pharma 2020: The vision-Which path will you take?, developed by PricewaterhouseCoopers (PwC). Pharmaceutical companies everywhere, the report says, have fewer new compounds in the pipeline, poor financial performance, rising sales and marketing expenditures, increased legal and regulatory challenges, and a tarnished reputation.
展开▼
